These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 7712113)
1. Selective increase in expression of isoform PP1 gamma 1 of type-1 protein phosphatase in chondrosarcoma cells. Sogawa K; Yamada T; Funamoto Y; Kohno K; Nishikawa H; Kishida F; Hamazaki F; Yamashita N; Matsumoto K Res Commun Mol Pathol Pharmacol; 1994 Dec; 86(3):375-8. PubMed ID: 7712113 [TBL] [Abstract][Full Text] [Related]
2. Role of protein phosphatase in malignant osteogenic and soft tissue tumors. Sogawa K; Yamada T; Sugita A; Kito K; Tachibana M; Nezu K; Ueda N Res Commun Mol Pathol Pharmacol; 1996 Jul; 93(1):33-42. PubMed ID: 8865368 [TBL] [Abstract][Full Text] [Related]
3. Enhanced expression of catalytic subunit isoform PP1 gamma 1 of protein phosphatase type 1 in malignant fibrous histiocytoma. Yamada T; Sogawa K; Masaki T; Funamoto Y; Kohno K; Oka S; Norimatsu H; Matsumoto K Res Commun Mol Pathol Pharmacol; 1994 Oct; 86(1):125-8. PubMed ID: 7850251 [TBL] [Abstract][Full Text] [Related]
4. Enhanced expression of catalytic subunits of protein phosphatase type 1 and high S-phase fraction in liposarcoma. Sogawa K; Yamada T; Masaki T; Nishikawa H; Cai Y; Oka S; Norimatsu H; Matsumoto K Res Commun Mol Pathol Pharmacol; 1994 Sep; 85(3):359-62. PubMed ID: 7827812 [TBL] [Abstract][Full Text] [Related]
5. Enhanced expression of catalytic subunit isoform PP1 gamma 1 of protein phosphatase type 1 associated with malignancy of osteogenic tumor. Sogawa K; Yamada T; Oka S; Kawasaki K; Mori S; Tanaka H; Norimatsu H; Cai Y; Kuwabara H; Shima H Cancer Lett; 1995 Feb; 89(1):1-6. PubMed ID: 7882291 [TBL] [Abstract][Full Text] [Related]
6. Chondrosarcoma is not characterized by detectable telomerase activity. Bovée JV; van Den Broek LJ; Cleton-Jansen AM; Hogendoorn PC J Pathol; 2001 Mar; 193(3):354-60. PubMed ID: 11241416 [TBL] [Abstract][Full Text] [Related]
7. Immunolocalization of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human chondrosarcomas. Kawashima A; Okada Y; Nakanishi I; Ueda Y; Iwata K; Roessner A Gen Diagn Pathol; 1997 Feb; 142(3-4):129-37. PubMed ID: 9065576 [TBL] [Abstract][Full Text] [Related]
8. Chondroma and chondrosarcoma. Kitagawa T Kumamoto Med J; 1974 Mar; 27(1):55-65. PubMed ID: 4437132 [No Abstract] [Full Text] [Related]
9. Malignant transformation in human chondrosarcoma cells supported by telomerase activation and tumor suppressor inactivation. Martin JA; Forest E; Block JA; Klingelhutz AJ; Whited B; Gitelis S; Wilkey A; Buckwalter JA Cell Growth Differ; 2002 Sep; 13(9):397-407. PubMed ID: 12354749 [TBL] [Abstract][Full Text] [Related]
10. Enchondroma protuberans. Report of a case and its distinction from chondrosarcoma and osteochondroma adjacent to an enchondroma. Crim JR; Mirra JM Skeletal Radiol; 1990; 19(6):431-4. PubMed ID: 2218592 [TBL] [Abstract][Full Text] [Related]
11. Evidence of an association between 6q13-21 chromosome aberrations and locally aggressive behavior in patients with cartilage tumors. Sawyer JR; Swanson CM; Lukacs JL; Nicholas RW; North PE; Thomas JR Cancer; 1998 Feb; 82(3):474-83. PubMed ID: 9452264 [TBL] [Abstract][Full Text] [Related]
12. Epidemiology of bone tumors in Mexico City: retrospective clinicopathologic study of 566 patients at a referral institution. Baena-Ocampo Ldel C; Ramirez-Perez E; Linares-Gonzalez LM; Delgado-Chavez R Ann Diagn Pathol; 2009 Feb; 13(1):16-21. PubMed ID: 19118777 [TBL] [Abstract][Full Text] [Related]
13. Correlation between clinicopathological features and karyotype in 100 cartilaginous and chordoid tumours. A report from the Chromosomes and Morphology (CHAMP) Collaborative Study Group. Tallini G; Dorfman H; Brys P; Dal Cin P; De Wever I; Fletcher CD; Jonson K; Mandahl N; Mertens F; Mitelman F; Rosai J; Rydholm A; Samson I; Sciot R; Van den Berghe H; Vanni R; Willén H J Pathol; 2002 Feb; 196(2):194-203. PubMed ID: 11793371 [TBL] [Abstract][Full Text] [Related]
14. Minichromosome maintenance protein (MCM6) in low-grade chondrosarcoma: distinction from enchondroma and identification of progressive tumors. Helfenstein A; Frahm SO; Krams M; Drescher W; Parwaresch R; Hassenpflug J Am J Clin Pathol; 2004 Dec; 122(6):912-8. PubMed ID: 15539383 [TBL] [Abstract][Full Text] [Related]
17. Transformation of solitary osteochondroma calcaneum to chondrosarcoma--a case report. Malik R; Kapoor N; Malik R Indian J Pathol Microbiol; 2004 Jan; 47(1):42-3. PubMed ID: 15471126 [TBL] [Abstract][Full Text] [Related]
18. Endogenous secretory receptor for advanced glycation endproducts as a novel prognostic marker in chondrosarcoma. Takeuchi A; Yamamoto Y; Tsuneyama K; Cheng C; Yonekura H; Watanabe T; Shimizu K; Tomita K; Yamamoto H; Tsuchiya H Cancer; 2007 Jun; 109(12):2532-40. PubMed ID: 17497647 [TBL] [Abstract][Full Text] [Related]